Filing Details

Accession Number:
0001209191-20-007871
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-10 16:14:40
Reporting Period:
2020-02-06
Accepted Time:
2020-02-10 16:14:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334365 Yuchun Lee C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-06 2,000 $57.27 3,875 No 4 M Direct
Common Stock Disposition 2020-02-06 1,071 $238.71 2,804 No 4 S Direct
Common Stock Disposition 2020-02-06 400 $239.28 2,404 No 4 S Direct
Common Stock Disposition 2020-02-06 429 $240.65 1,975 No 4 S Direct
Common Stock Disposition 2020-02-06 100 $244.08 1,875 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-02-06 2,000 $0.00 2,000 $57.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,306 2022-09-13 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $238.71 (range $238.15 to $239.13).
  3. Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $239.28 (range $239.20 to $239.45).
  5. Open market sales reported on this line occurred at a weighted average price of $240.65 (range $240.39 to $241.36).
  6. Fully vested.